Yahoo España Búsqueda web

Search results

  1. Daphne Koller (Hebrew: דפנה קולר; born August 27, 1968) is an Israeli-American computer scientist. She was a professor in the department of computer science at Stanford University and a MacArthur Foundation fellowship recipient. She is one of the founders of Coursera, an online education platform.

  2. Daphne Koller (Jerusalén, 27 de agosto de 1968) es una profesora israelo-americana del Departamento de Informática de la Universidad de Stanford, ganadora de una beca MacArthur. Es también una de las fundadoras de Coursera, una plataforma de educación en línea.

  3. www.insitro.com › leadership › daphne-kollerDaphne Koller - insitro

    Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients. She was the co-founder, co-CEO, and president of online education platform Coursera, the largest platform for massive open online courses (MOOCs), which has reached ...

  4. Daphne Koller is a Stanford professor and computer scientist who studies probabilistic graphical models and online education. She co-founded Coursera, a platform that offers free courses from top colleges, and gave a TED talk on what we're learning from online education.

  5. Support vector machine active learning with applications to text classification. S Tong, D Koller. Journal of machine learning research 2 (Nov), 45-66. , 2001. 3797. 2001. A gene-coexpression network for global discovery of conserved genetic modules. JM Stuart, E Segal, D Koller, SK Kim. science 302 (5643), 249-255.

  6. Daphne Koller is a leading researcher in machine learning and probabilistic methods, and the founder of CURIS, a summer program for undergraduates. She also teaches online courses on Coursera, covering topics such as computational biology, medicine, and semantic understanding.

  7. 25 de oct. de 2023 · Koller is an adjunct professor of computer science at Stanford. Koller explained a two-step process that can lead to novel drug targets for cancer. In the first step, Insitro machine learning...